vs

Side-by-side financial comparison of Dexcom (DXCM) and PRICESMART INC (PSMT). Click either name above to swap in a different company.

PRICESMART INC is the larger business by last-quarter revenue ($1.4B vs $1.3B, roughly 1.1× Dexcom). Dexcom runs the higher net margin — 21.2% vs 2.9%, a 18.3% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 9.9%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 3.5%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

PriceSmart, Inc. is a United States based operator of membership warehouse clubs in Central America, the Caribbean, and South America. PriceSmart was founded by Sol and Robert Price, founders of Price Club; Robert Price is chairman of the board.

DXCM vs PSMT — Head-to-Head

Bigger by revenue
PSMT
PSMT
1.1× larger
PSMT
$1.4B
$1.3B
DXCM
Growing faster (revenue YoY)
DXCM
DXCM
+11.7% gap
DXCM
21.6%
9.9%
PSMT
Higher net margin
DXCM
DXCM
18.3% more per $
DXCM
21.2%
2.9%
PSMT
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
3.5%
PSMT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
DXCM
DXCM
PSMT
PSMT
Revenue
$1.3B
$1.4B
Net Profit
$267.3M
$40.2M
Gross Margin
62.9%
17.7%
Operating Margin
25.6%
4.6%
Net Margin
21.2%
2.9%
Revenue YoY
21.6%
9.9%
Net Profit YoY
153.6%
7.3%
EPS (diluted)
$0.67
$1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
PSMT
PSMT
Q1 26
$1.3B
Q4 25
$1.3B
$1.4B
Q3 25
$1.2B
$1.3B
Q2 25
$1.2B
$1.3B
Q1 25
$1.0B
$1.4B
Q4 24
$1.1B
$1.3B
Q3 24
$994.2M
$1.2B
Q2 24
$1.0B
$1.2B
Net Profit
DXCM
DXCM
PSMT
PSMT
Q1 26
$267.3M
Q4 25
$267.3M
$40.2M
Q3 25
$283.8M
$31.5M
Q2 25
$179.8M
$35.2M
Q1 25
$105.4M
$43.8M
Q4 24
$151.7M
$37.4M
Q3 24
$134.6M
$29.1M
Q2 24
$143.5M
$32.5M
Gross Margin
DXCM
DXCM
PSMT
PSMT
Q1 26
62.9%
Q4 25
62.9%
17.7%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
17.1%
Q4 24
58.9%
17.4%
Q3 24
59.7%
Q2 24
62.4%
Operating Margin
DXCM
DXCM
PSMT
PSMT
Q1 26
25.6%
Q4 25
25.6%
4.6%
Q3 25
20.1%
4.0%
Q2 25
18.4%
4.3%
Q1 25
12.9%
4.8%
Q4 24
17.0%
4.6%
Q3 24
15.3%
4.0%
Q2 24
15.7%
4.1%
Net Margin
DXCM
DXCM
PSMT
PSMT
Q1 26
21.2%
Q4 25
21.2%
2.9%
Q3 25
23.5%
2.4%
Q2 25
15.5%
2.7%
Q1 25
10.2%
3.2%
Q4 24
13.6%
3.0%
Q3 24
13.5%
2.4%
Q2 24
14.3%
2.6%
EPS (diluted)
DXCM
DXCM
PSMT
PSMT
Q1 26
$0.67
Q4 25
$0.67
$1.29
Q3 25
$0.70
$1.02
Q2 25
$0.45
$1.14
Q1 25
$0.27
$1.45
Q4 24
$0.37
$1.21
Q3 24
$0.34
$0.94
Q2 24
$0.35
$1.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
PSMT
PSMT
Cash + ST InvestmentsLiquidity on hand
$917.7M
$320.6M
Total DebtLower is stronger
$180.3M
Stockholders' EquityBook value
$2.7B
$1.3B
Total Assets
$6.3B
$2.4B
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
PSMT
PSMT
Q1 26
$917.7M
Q4 25
$917.7M
$320.6M
Q3 25
$1.8B
$314.2M
Q2 25
$1.2B
$262.4M
Q1 25
$904.9M
$247.3M
Q4 24
$606.1M
$222.2M
Q3 24
$621.2M
$225.5M
Q2 24
$939.2M
$228.2M
Total Debt
DXCM
DXCM
PSMT
PSMT
Q1 26
Q4 25
$180.3M
Q3 25
$186.6M
Q2 25
$103.1M
Q1 25
$107.1M
Q4 24
$115.6M
Q3 24
$130.4M
Q2 24
$135.1M
Stockholders' Equity
DXCM
DXCM
PSMT
PSMT
Q1 26
$2.7B
Q4 25
$2.7B
$1.3B
Q3 25
$2.7B
$1.2B
Q2 25
$2.6B
$1.2B
Q1 25
$2.3B
$1.2B
Q4 24
$2.1B
$1.2B
Q3 24
$2.0B
$1.1B
Q2 24
$2.4B
$1.1B
Total Assets
DXCM
DXCM
PSMT
PSMT
Q1 26
$6.3B
Q4 25
$6.3B
$2.4B
Q3 25
$7.5B
$2.3B
Q2 25
$7.3B
$2.1B
Q1 25
$6.8B
$2.1B
Q4 24
$6.5B
$2.1B
Q3 24
$6.4B
$2.0B
Q2 24
$6.8B
$2.0B
Debt / Equity
DXCM
DXCM
PSMT
PSMT
Q1 26
Q4 25
0.14×
Q3 25
0.15×
Q2 25
0.08×
Q1 25
0.09×
Q4 24
0.10×
Q3 24
0.12×
Q2 24
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
PSMT
PSMT
Operating Cash FlowLast quarter
$71.2M
Free Cash FlowOCF − Capex
$32.6M
FCF MarginFCF / Revenue
2.4%
Capex IntensityCapex / Revenue
2.8%
Cash ConversionOCF / Net Profit
1.77×
TTM Free Cash FlowTrailing 4 quarters
$125.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
PSMT
PSMT
Q1 26
Q4 25
$294.0M
$71.2M
Q3 25
$659.9M
$82.1M
Q2 25
$303.0M
$52.8M
Q1 25
$183.8M
$87.9M
Q4 24
$301.4M
$38.5M
Q3 24
$199.5M
$41.8M
Q2 24
$279.4M
$38.1M
Free Cash Flow
DXCM
DXCM
PSMT
PSMT
Q1 26
Q4 25
$192.1M
$32.6M
Q3 25
$579.4M
$25.6M
Q2 25
$208.9M
$14.0M
Q1 25
$96.8M
$53.2M
Q4 24
$176.8M
$10.3M
Q3 24
$88.3M
$15.2M
Q2 24
$213.3M
$-308.0K
FCF Margin
DXCM
DXCM
PSMT
PSMT
Q1 26
Q4 25
15.3%
2.4%
Q3 25
47.9%
1.9%
Q2 25
18.1%
1.1%
Q1 25
9.3%
3.9%
Q4 24
15.9%
0.8%
Q3 24
8.9%
1.2%
Q2 24
21.2%
-0.0%
Capex Intensity
DXCM
DXCM
PSMT
PSMT
Q1 26
Q4 25
8.1%
2.8%
Q3 25
6.7%
4.2%
Q2 25
8.1%
2.9%
Q1 25
8.4%
2.5%
Q4 24
11.2%
2.2%
Q3 24
11.2%
2.2%
Q2 24
6.6%
3.1%
Cash Conversion
DXCM
DXCM
PSMT
PSMT
Q1 26
Q4 25
1.10×
1.77×
Q3 25
2.33×
2.60×
Q2 25
1.69×
1.50×
Q1 25
1.74×
2.01×
Q4 24
1.99×
1.03×
Q3 24
1.48×
1.44×
Q2 24
1.95×
1.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

PSMT
PSMT

Fresh Foods$454.9M33%
Caribbean Operations Segment$396.5M29%
Colombia Operations Segment$204.1M15%
Hardlines$162.6M12%
Softlines$99.8M7%
ship Income Member$24.5M2%
Health Services$14.5M1%
Other Revenue And Income$4.2M0%
United States Operations Segment$510.0K0%
Export Sales$359.0K0%

Related Comparisons